1. Introduction
===============

*Abrus precatorius* Linn belongs to the family Leguminosae. Its seeds, known as Xiang-si-zi, have been used in China as an insecticide and for treatment of some skin diseases since ancient times \[[@B1-molecules-17-00295]\]. Besides, the leaves and roots are sweetish and traditionally used to cure fever, stomatitis, asthma and bronchititis \[[@B2-molecules-17-00295]\]. Several groups of biologically active secondary compounds including alkaloids \[[@B3-molecules-17-00295]\], flavones \[[@B4-molecules-17-00295]\], triterpenoids \[[@B5-molecules-17-00295]\] and isoflavano-quinones \[[@B6-molecules-17-00295]\] have been isolated from this plant, some of which possess anti-inflammatory \[[@B7-molecules-17-00295]\], antibiosis \[[@B8-molecules-17-00295]\], antiplatelet \[[@B9-molecules-17-00295]\], and anti-implantation \[[@B10-molecules-17-00295]\] properties. In our research on bioactive compounds from *Abrus precatorius* collected from the mangrove wetlands of Hainan Island, China, a new 3-O-*β*-[D]{.smallcaps}-glucopyranosyl-(1→2)-*β*-[D]{.smallcaps}-glucopyranosyl subprogenin D (**1**), as well as six known ones (compounds **2**--**7**) were obtained. The structure of the new compound was elucidated using 1D, 2D NMR and MS experiments, while the configuration of **1** was defined by NOESY spectroscopy. Compounds **2**--**7** were identified as subprogenin D (**2**) \[[@B11-molecules-17-00295]\], abrusgenic acid (**3**) \[[@B12-molecules-17-00295]\], triptotriterpenic acid B (**4**) \[[@B13-molecules-17-00295]\], abruslactone A (**5**) \[[@B14-molecules-17-00295]\], abrusogenin (**6**) \[[@B15-molecules-17-00295]\] and abrusoside C (**7**) \[[@B15-molecules-17-00295]\], respectively, by comparison of their spectroscopic data with those reported in the literature. Compounds **1**, **2** and **4** were isolated from this plant for the first time.

2. Results and Discussion
=========================

The aqueous EtOH extract of the *Abrus precatorius* was suspended in water, and then partitioned with petroleum ether, EtOAc, and *n*-butanol by liquid-liquid extraction respectively. The EtOAc and *n*-butanol fractions were successively subjected to repeated silica gel column, Sephadex LH-20 to yield compounds **1**--**7** ([Figure 1](#molecules-17-00295-f001){ref-type="fig"}).

![Structures of compounds **1**--**7**.](molecules-17-00295-g001){#molecules-17-00295-f001}

Compound **1** had the molecular formula C~42~H~66~O~14~ as deduced from HRESI-MS *m/z* 817.4345 \[M+Na\]^+^ (calcd for C~42~H~66~O~14~Na, 817.4350) and NMR data ([Table 1](#molecules-17-00295-t001){ref-type="table"}). The IR spectrum exhibited absorption bands at 3458 (OH), 1727(C=O), 1693(C=O) and 1624 (C=C) cm^--1^. Seven methyl groups (δ~H~ 1.42, 1.32, 1.27, 1.23, 1.14, 0.91 and 0.86), one oxygenated methine proton (δ~H~ 3.29, dd, *J* = 5.0, 11.0 Hz), and one olefinic proton (δ~H~ 5.31, br s) were observed in the ^1^H-NMR spectrum. The ^13^C-NMR and DEPT data confirmed the presence of seven methyl carbons (δ~C~ 28.1, 25.5, 21.6, 20.9, 16.8, 16.7, 15.6), two olefinic carbons (δ~C~ 124.7, 141.4), one oxygenated methine carbons (δ~C~ 89.0), a carbonyl carbon (δ~C~ 214.9) and a carboxylic carbon (δ~C~ 178.6) ([Table 1](#molecules-17-00295-t001){ref-type="table"}). The ^1^H- and ^13^C-NMR spectra of **1** has the characteristic of Δ^12^ oleanene skeleton \[[@B16-molecules-17-00295]\]. Comparison the ^13^C-NMR data of **1** with **2** except for the C-3 signal (δ~C~ 89.0) which shifted down field by 11 ppm, others were in accordance with that of 3*β*-hydroxy-22-oxo-12-oleanen-29-oic acid (**2**) \[[@B11-molecules-17-00295]\]. The locations of carbonyl carbon and carboxylic carbon could be confirmed by the HMBC correlations from δ~H~ 1.23 (Me-28) to δ~C~ 214.9, 26.6 (C-16), and δ~H~ 1.42 (Me-30) to δ~C~ 178.6, 41.6 (C-19), 46.5 (C-21) ([Figure 2](#molecules-17-00295-f002){ref-type="fig"}). Moreover, the ^1^H and ^13^C-NMR spectra of **1** showed two sugar anomeric protons at δ~H~ 5.26 (1H, d, *J* = 7.0 Hz) and δ~H~ 5.03 (1H, d, *J* = 7.0 Hz) and carbons at δ~C~ 107.2 and 105.3 ([Table 1](#molecules-17-00295-t001){ref-type="table"}). The monosaccharides were analysed as *β*-[D]{.smallcaps}-glucose with acetylated alditols derivatives by GC using authentic samples as references after hydrolysis of **1**. This also could be validated by a combination of the coupling constants (*J* = 7.0 Hz for H-1″ and *J* = 7.0 Hz for H-1′) and 1D, 2D-NMR experiments. The signal at δ~C~ 89.0 in the ^13^C-NMR suggesting that the *β*-[D]{.smallcaps}-glucose moieties are linked to the oxygen at C-3 of the aglycon \[[@B17-molecules-17-00295]\].This deduction and sequence of inter-glycosidic linkages were deduced from the following HMBC correlations: H-1′ (δ~H~ 5.03) of inner glucose with C-3 (δ~C~ 89.0) of sapogenin, H-1′′ (δ~H~ 5.26) of terminal glucose with C-2′ (δ~C~ 83.9) ([Figure 2](#molecules-17-00295-f002){ref-type="fig"}). The relative configuration of the hydroxylated carbon (C-3) was assigned as *β* form mainly on the basis of ^1^H-NMR coupling (1H, dd, *J* = 5.0, 11.0 Hz, H-3) \[[@B17-molecules-17-00295]\] and by comparison with **2**. In NOESY spectrum, the key NOE correlations of H-28/H-21β, H-28/H-18 and H-30/H-18, showed that H-30, H-28, H-21β, H-18 were on the same face, so the relative stereochemistry were determined ([Figure 3](#molecules-17-00295-f003){ref-type="fig"}).
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###### 

^1^H- (500 MHz) and ^13^C-NMR (125 MHz) data of compound **1** (in Pyr-d~5~, *δ* in ppm, *J* in Hz).

  No.                                     δ~C~         δ~H~                                     Key HMBC (H to C)
  --------------------------------------- ------------ ---------------------------------------- -------------------
  1                                       38.7 CH~2~   1.40 (1H, m, H-1a)0.82 (1H, m, H-1b)     C-2,C-3
  2                                       27.3 CH~2~   2.24 (2H, m, H-2)                        C-1,C-3
  3                                       89.0 CH      3.29 (1H, dd, *J* = 5.0, 11.0 Hz, H-3)   C-1′, 23, 24
  4                                       39.5 qC                                               
  5                                       55.6 CH      0.71 (1H, br d, *J* = 11.5 Hz, H-5)      C-23,24,25
  6                                       18.4 CH~2~   1.64 (1H, m, H-6a),                      C-24
  1.46 (1H, m, H-6b)                                                                            
  7                                       32.8 CH~2~   1.48 (1H, m, H-7a),                      
  1.29 (1H, m, H-7b)                                                                            
  8                                       39.9 qC                                               
  9                                       47.6 CH      1.56 (1H, m, H-9)                        
  10                                      36.8 qC                                               
  11                                      23.8 CH~2~   1.84 (2H, m, H-11)                       
  12                                      124.7 CH     5.31 (1H, br s, H-12)                    
  13                                      141.4 qC                                              
  14                                      41.9 qC                                               
  15                                      25.5 CH~2~   1.68 (1H, m, H-15a),                     
  0.98 (1H, m, H-15b)                                                                           
  16                                      26.6 CH~2~   1.89 (1H, m, H-16a),                     C-28
  1.28 (1H, m, H-16b)                                                                           
  17                                      48.2 qC                                               
  18                                      47.0 CH      2.54 (1H, m, H-18)                       
  19                                      41.6 CH~2~   2.88 (1H, t, *J* = 13.5 Hz, H-19a),      C-30
  1.97 (1H, br d, *J* = 12.0 Hz, H-19b)                                                         
  20                                      44.6 qC                                               
  21                                      46.5 CH~2~   3.46 (1H, d, *J* = 14.5 Hz, H-21a),      C-30
  2.71 (1H, br d, *J* = 14.0 Hz, H-21b)                                                         
  22                                      214.9 qC                                              
  23                                      28.1 CH~3~   1.32 (3H, s, Me-23)                      C-3
  24                                      15.6 CH~3~   0.86 (3H, s, Me-24)                      C-3
  25                                      16.7 CH~3~   0.91 (3H, s, Me-25)                      
  26                                      16.8 CH~3~   1.14 (3H, s, Me-26)                      
  27                                      25.5 CH~3~   1.27 (3H, s, Me-27)                      C-13
  28                                      20.9 CH~3~   1.23 (3H, s, Me-28)                      C-22,C-16
  29                                      178.6 qC                                              
  30                                      21.6 CH~3~   1.42 (3H, s, Me-30)                      C-29,C-19,C-21
  glu                                                                                           
  1′                                      105.3 CH     5.03 (1H, d, *J* = 7.0 Hz, H-1′)         C-3
  2′                                      83.9 CH      4.33 (1H, t, *J* = 8.0 Hz, H-2′)         C-1′,C-1″,C-4′
  3′                                      77.7 CH      4.40 (1H, br d, *J* = 8.0 Hz, H-3′)      
  4′                                      73.1 CH      4.64 (3H, m, H-4′, 2″, 3″)               
  5′                                      74.7 CH      4.20 (1H, br d, *J* = 9 Hz, H-5′)        
  6′                                      61.3 CH~2~   4.44 (2H, m, H-6′)                       
  glu                                                                                           
  1″                                      107.2 CH     5.26 (1H, d, *J* = 7.0 Hz, H-1″)         C-2′,C-3″
  2″                                      74.9 CH      4.64 (3H, m, H-4′, 2″, 3″)               C-4″
  3″                                      77.4 CH      4.64 (3H, m, H-4′, 2″, 3″)               
  4″                                      69.5 CH      4.73 (1H, m, H-4″)                       
  5″                                      76.9 CH      4.09 (1H, t, *J* = 6.1 Hz, H-5″)         
  6″                                      61.3 CH~2~   4.67 (2H, m, H-6″)                       

![Key HMBC and COSY correlations of **1**.](molecules-17-00295-g002){#molecules-17-00295-f002}

![Key NOESY correlations of **1**.](molecules-17-00295-g003){#molecules-17-00295-f003}

All the above data identified **1** as 3-O-*β*-[D]{.smallcaps}-glucopyranosyl-(1→2)-*β*-[D]{.smallcaps}-glucopyranosyl subprogenin D. The structures of known compounds **2**--**7** were confirmed by detailed NMR data comparison with those in the literature \[[@B11-molecules-17-00295],[@B12-molecules-17-00295],[@B13-molecules-17-00295],[@B14-molecules-17-00295],[@B15-molecules-17-00295]\].

The cytotoxicity of **1**--**7** against MCF-7, SW1990, Hela, Du-145 cancer cell lines were evaluated with 5-FU (5-Fluorouracil) and DOX (doxorubicine) as positive controls. Compound **5** showed moderate cytoxicity against SW1990, Hela, Du-145 cancer cell lines, and compound **6** showed moderate cytoxicity against MCF-7, SW1990, Du-145 cancer cell lines, whereas other compounds had no significant activity ([Table 2](#molecules-17-00295-t002){ref-type="table"}).
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###### 

Cytotoxicity of **1**--**7** against four cancer cell lines.

         Cytotoxicity (IC~50~ \[μg/mL\])(mean ± SD%)                           
  ------ --------------------------------------------- ----------- ----------- ----------
  1      \-^a^                                         \-          \-          \-
  2      \-                                            \-          \-          \-
  3      \-                                            \-          \-          \-
  4      \-                                            \-          \-          \-
  5      \-                                            5 ± 0.32    10 ± 0.89   5 ± 0.40
  6      4 ± 0.18                                      2 ± 0.09    \-          2 ± 0.08
  7      \-                                            \-          \-          \-
  DOX    1 ± 0.06                                                  2 ± 0.16    1 ± 0.05
  5-Fu                                                 10 ± 0.95               

^a^ No significant activity at 10 μg/mL.

3. Experimental
===============

3.1. General
------------

1D and 2D NMR spectra were recorded on a Bruker-AV-500 spectrometer with TMS as internal standard. HRESIMS were measured with MAT 95XP mass spectrometer. IR were recorded on FT-IR Nicolet 6700. UV spectra were obtained on a Beckman DU-640 UV spectrophotometer. Optical rotations were measured with a Perkin-Elmer 341 plus. GC were run on a QP2010PLUS (Shimadzu Corporation) equipped with an ACQ mass spectrometer. For column chromatography (CC), silica gel (200--300 mesh) and GF~254~ for TLC were obtained from the Qingdao Marine Chemical Factory, Qingdao, China.

3.2. Plant Material
-------------------

The leaves and stems of *Abrus precatorius* were collected in October 2010 from the mangrove wetlands of Hainan Island, China. The identification of the plant was performed by Professor Si Zhang. A voucher sample (No. 20101001) is maintained in the Key Laboratory of Marine Bio-Resources Sustainable Utilization, South China Sea Institute of Oceanology, Chinese Academy of Sciences, China.

3.3. Extraction and Isolation
-----------------------------

The air-dried leaves and stems of *Abrus precatorius* (8 kg) were extracted with EtOH (95%, 20 L) three times (7 days each time) at room temperature. The combined extract was evaporated *in vacuo*, suspended in water, and then successively partitioned with petroleum ether, EtOAc, and *n*-butanol (800 mL × 3). The EtOAc and *n*-butanol fractions were concentrated to afford 53.7 g and 108 g of residues, resp. The EtOAc extract was subjected to silica gel CC using a gradient elution of CHCl~3~-MeOH (100:0--1:1) to afford ten fractions (Frs. **A**--**J**). Compound **3** (11 mg) was crystallizated in the bottle when eluted with the solvent CHCl~3~-MeOH 90:10 (Frs. **B**) and then purified with MeOH. Frs. **B** (7 g) was subjected to CC and eluted with CHCl~3~-acetone (30:1, 20:1, 15:1, 10:1, 5:1, each 1500 mL) to give six fractions (**B1**--**B6**), **B3** was purified by Sexphadex LH-20 (CHCl~3~-MeOH 1:1) to yield **2** (8 mg). Compound **4** (10 mg) was isolated from **B1** by repeated chromatographic on Sephadex LH-20 (CHCl~3~-MeOH 1:1) and silica gel column (CHCl~3~-MeOH 80:1). Frs. **C** (4.4 g) was subjected to CC with gradient eluting of CHCl~3~-acetone (30:1, 20:1, 15:1, 10:1, 5:1, each 1,000 mL) to give six fractions (**C1**--**C6**). Compound **5** (7 mg) was crystallizated from **C2** when eluted with the solvent CHCl~3~-acetone 20:1, and then recrystallizated with MeOH. **C4** was purified by Sexphadex LH-20 (CHCl~3~-MeOH 1:1) to give compound **6** (7 mg). Frs. **G** (2.36 g) was subjected to CC with gradient eluting of CHCl~3~-MeOH (30:1, 20:1, 15:1, 10:1, 5:1, each 500 mL) and purification on Sephadex LH-20 to yield **7** (20 mg). The *n*-BuOH extract (108 g) was subjected to CC on Amberlite XAD using MeOH-H~2~O (20%, 40%, 60% and 95%). The 40% extract part (7.23 g) was fractioned on silica gel column eluting with CHCl~3~-MeOH-H~2~O 9:1:0.1 to give ten fraction **H**--**Q**. Fraction **Q** (0.4265 g) was purified by Sexphadex LH-20 (CHCl~3~-MeOH 1:1) to give compound **1** (5 mg). Yellow powder: ![](molecules-17-00295-i001.jpg) = −10 (*c* = 0.04, MOH), UV (MeOH) λ~max~ 255 nm, IR (KBr) ν~max~: 3458, 2946, 1727, 1693, 1624, 1466, 1383, 1211, 1042 cm^−1^; HRESI-MS *m/z* 817.4345 \[M+Na\]^+^ (calcd for C~42~H~66~O~14~Na, 817.4350). ^1^H and ^13^C-NMR data see [Table 1](#molecules-17-00295-t001){ref-type="table"}.

3.4. Acid Hydrolysis of ***1***
-------------------------------

Compound **1** (2 mg) was added into 3 N HCl (0.5 mL) and refluxed for 5 h in a water bath (100 °C). The solution was neutralized and extracted with EtOAc to afford the aglycon. The aglycon of **1** found to be identical with **2** by TLC. The sugars released were converted into acetylated alditols by reduction with NaBH~4~ followed by acetylation with acetic anhydride-pyridine mixture. The alditol acetates derivatives obtained were analyzed by GC using a GCMS-QP2010 Plus: The injector temperature was set at 250 °C and the column temperature program was as follows: The initial temperature of 200 °C was held constant for 2.5 min and then increased by 5 °C min to the final temperature of 250 °C. The detector temperature was set at 280 °C. MS-Scan: ACQ mode, event Time: 0.50 s with 1,000 scan speed. Alditol acetates were identified by comparison of their retention times with those of authentic samples \[[@B16-molecules-17-00295]\].

3.5. Cytotoxicity Assays
------------------------

Cytotoxicity was evaluated by the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide\] method using MCF-7, SW1990, Hela and Du-145 cell lines. Details of the assays were described in a previous report \[[@B18-molecules-17-00295]\].

4. Conclusions
==============

The new compound 3-*O*-*β*-[D]{.smallcaps}-glucopyranosyl-(1→2)-*β*-[D]{.smallcaps}-glucopyranosyl subprogenin D (**1**) was isolated from *Abrus precatorius*, together with six known triterpenoids. Compounds **5** and **6** showed moderate cytoxicities against MCF-7, SW1990, Hela and Du-145. However, the new compound **1** and the other known ones had no significant activity.
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